Nom du produit:2-cyclobutyl-1H-1,3-benzodiazol-5-amine dihydrochloride

IUPAC Name:2-cyclobutyl-1H-1,3-benzodiazol-5-amine dihydrochloride

CAS:1221722-70-8
Formule moléculaire:C11H15Cl2N3
Pureté:95%+
Numéro de catalogue:CM454083
Poids moléculaire:260.16

Unité d'emballage Stock disponible Prix($) Quantité
CM454083-250mg 3-4 Weeks Ŕƅƅ
CM454083-500mg 3-4 Weeks ňňș
CM454083-1g 3-4 Weeks șŭŭ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1221722-70-8
Formule moléculaire:C11H15Cl2N3
Point de fusion:-
Code SMILES:Cl.Cl.NC1=CC2=C(NC(=N2)C2CCC2)C=C1
Densité:
Numéro de catalogue:CM454083
Poids moléculaire:260.16
Point d'ébullition:
N° Mdl:MFCD15209650
Stockage:

Category Infos

Benzimidazoles
Benzimidazole is a benzo derivative of imidazole. It is a kind of bicyclic aromatic organic compounds, which is formed by fusing a six-membered benzene ring and five-membered imidazole at positions 4 and 5 of imidazole ring. It is an important pharmacophore of many biologically active heterocyclic compounds with various pharmacological activities. Benzimidazoles and their derivatives have developed into dynamic heterocyclic systems due to their potency in a variety of biologically active compounds such as anticancer, bactericidal and antiviral drugs. Benzimidazoles are a class of therapeutic motifs with broad relevance in medicinal chemistry.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products